ATLANTA, GA USA (UroToday) - Abiraterone acetate inhibits CYP17, an enzyme complex needed for androgen biosynthesis, and when used in combination with prednisone improved the overall survival in patients with mCRPC who received prior chemotherapy containing docetaxel.
Provided by Judd W. Moul, MD, FACS from his presentation at at the American Urological Association (AUA) Annual Meeting - May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA
